相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Viral vectors for therapy of neurologic diseases
Sourav R. Choudhury et al.
NEUROPHARMACOLOGY (2017)
Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome
Michele Ferrari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Live birth derived from oocyte spindle transfer to prevent mitochondrial disease
John Zhang et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2017)
Leigh syndrome: One disorder, more than 75 monogenic causes
Nicole J. Lake et al.
ANNALS OF NEUROLOGY (2016)
Free-thiamine is a potential biomarker of thiamine transporter-2 deficiency: a treatable cause of Leigh syndrome
Juan Dario Ortigoza-Escobar et al.
BRAIN (2016)
First live birth using human oocytes reconstituted by spindle nuclear transfer for mitochondrial DNA mutation causing Leigh syndrome
J. Zhang et al.
FERTILITY AND STERILITY (2016)
Adeno-Associated Virus-Based Gene Therapy for CNS Diseases
Michael Hocquemiller et al.
HUMAN GENE THERAPY (2016)
Genotoxicity in Mice Following AAV Gene Delivery: A Safety Concern for Human Gene Therapy?
Randy J. Chandler et al.
MOLECULAR THERAPY (2016)
Mitochondrial disease therapy from thin air?
Eric A. Shoubridge
SCIENCE (2016)
Hypoxia as a therapy for mitochondrial disease
Isha H. Jain et al.
SCIENCE (2016)
Response to immunotherapy in a patient with adult onset Leigh syndrome and T9176C mtDNA mutation
Miguel Chuquilin et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2016)
Phenotypic variation of TTC19-deficient mitochondrial complex III deficiency: A case report and literature review
Dylan A. Mordaunt et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2015)
LRPPRC mutations cause early-onset multisystem mitochondrial disease outside of the French-Canadian population
Monika Olahova et al.
BRAIN (2015)
Glial Lipid Droplets and ROS Induced by Mitochondrial Defects Promote Neurodegeneration
Lucy Liu et al.
CELL (2015)
Opa1 Overexpression Ameliorates the Phenotype of Two Mitochondrial Disease Mouse Models
Gabriele Civiletto et al.
CELL METABOLISM (2015)
Mitochondrial disorders: Challenges in diagnosis & treatment
Kumarasamy Thangaraj et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2015)
Leigh Syndrome: Neuropathology and Pathogenesis
Nicole J. Lake et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas
Jean-Charles Nault et al.
NATURE GENETICS (2015)
Mutations causing mitochondrial disease: What is new and what challenges remain?
Robert N. Lightowlers et al.
SCIENCE (2015)
Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society
Sumit Parikh et al.
GENETICS IN MEDICINE (2015)
Mild clinical manifestation and unusual recovery upon coenzyme Q10 treatment in the first Chinese Leigh syndrome pedigree with mutation m.10197 G>A
Zhiting Chen et al.
MOLECULAR MEDICINE REPORTS (2015)
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease
Michael S. Rafii et al.
ALZHEIMERS & DEMENTIA (2014)
A Founder Mutation in PET100 Causes Isolated Complex IV Deficiency in Lebanese Individuals with Leigh Syndrome
Sze Chern Lim et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2014)
Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease
Tobias B. Haack et al.
BRAIN (2014)
Turn up the power pharmacological activation of mitochondrial biogenesis in mouse models
J. C. Komen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Pharmacological Inhibition of Poly(ADP-Ribose) Polymerases Improves Fitness and Mitochondrial Function in Skeletal Muscle
Eija Pirinen et al.
CELL METABOLISM (2014)
NAD+-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial Disease
Raffaele Cerutti et al.
CELL METABOLISM (2014)
Biosafety of Recombinant Adeno-associated Virus Vectors
David Dismuke et al.
CURRENT GENE THERAPY (2014)
Beneficial effects of resveratrol on respiratory chain defects in patients fibroblasts involve estrogen receptor and estrogen-related receptor alpha signaling
Alexandra Lopes Costa et al.
HUMAN MOLECULAR GENETICS (2014)
A mutation in the human CBP4 ortholog UQCC3 impairs complex III assembly, activity and cytochrome b stability
Bas F. J. Wanschers et al.
HUMAN MOLECULAR GENETICS (2014)
Loss of LRPPRC causes ATP synthase deficiency
Arnaud Mourier et al.
HUMAN MOLECULAR GENETICS (2014)
Coenzyme Q10 as a therapy for mitochondrial disease
I.P. Hargreaves
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
A guide to diagnosis and treatment of Leigh syndrome
Fabian Baertling et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Efficacy of pyruvate therapy in patients with mitochondrial disease: A semi-quantitative clinical evaluation study
Tatsuya Fujii et al.
MOLECULAR GENETICS AND METABOLISM (2014)
PARP Inhibition Delays Progression of Mitochondrial Encephalopathy in Mice
Roberta Felici et al.
NEUROTHERAPEUTICS (2014)
A target for pharmacological intervention in an untreatable human disease
Simon C. Johnson
SCIENCE (2014)
Complex II deficiencyA case report and review of the literature
Shailly Jain-Ghai et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2013)
Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy
Natalie Noe et al.
MITOCHONDRION (2013)
Glutathione: A redox signature in monitoring EPI-743 therapy in children with mitochondrial encephalomyopathies
Anna Pastore et al.
MOLECULAR GENETICS AND METABOLISM (2013)
mTOR is a key modulator of ageing and age-related disease
Simon C. Johnson et al.
NATURE (2013)
Treating mitochondrial diseases with mTOR inhibitors—a potential treatment for Leigh syndrome?
Tim Geach
Nature Reviews Neurology (2013)
SURF1 deficiency: a multi-centre natural history study
Yehani Wedatilake et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome
Simon C. Johnson et al.
SCIENCE (2013)
Medical treatment with thiamine, coenzyme Q, vitamins E and C, and carnitine improved obstructive sleep apnea in an adult case of Leigh disease
Charalampos Mermigkis et al.
SLEEP AND BREATHING (2013)
Mitochondrial Encephalomyopathy Due to a Novel Mutation in ACAD9
Caterina Garone et al.
JAMA NEUROLOGY (2013)
SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function
Nathan L. Price et al.
CELL METABOLISM (2012)
Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
Gabriele Mittermeyer et al.
HUMAN GENE THERAPY (2012)
SURF1-Associated Leigh Syndrome: A Case Series and Novel Mutations
Inn-Chi Lee et al.
HUMAN MUTATION (2012)
Fatal breathing dysfunction in a mouse model of Leigh syndrome
Albert Quintana et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Complex I deficiency: clinical features, biochemistry and molecular genetics
Elisa Fassone et al.
JOURNAL OF MEDICAL GENETICS (2012)
EPI-743 reverses the progression of the pediatric mitochondrial disease-Genetically defined Leigh Syndrome
Diego Martinelli et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Thiamine Pyrophosphokinase Deficiency in Encephalopathic Children with Defects in the Pyruvate Oxidation Pathway
Johannes A. Mayr et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene
Mike Gerards et al.
BRAIN (2011)
PARP-1 Inhibition Increases Mitochondrial Metabolism through SIRT1 Activation
Peter Bai et al.
CELL METABOLISM (2011)
In Vivo Correction of COX Deficiency by Activation of the AMPK/PGC-1α Axis
Carlo Viscomi et al.
CELL METABOLISM (2011)
Pyruvate therapy for Leigh syndrome due to cytochrome c oxidase deficiency
Hirofumi Komaki et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2010)
Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC
Piotr Hadaczek et al.
MOLECULAR THERAPY (2010)
A RANDOMIZED TRIAL OF COENZYME Q10 IN MITOCHONDRIAL DISORDERS
Elisa I. Glover et al.
MUSCLE & NERVE (2010)
Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome
Albert Quintana et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A modern approach to the treatment of mitochondrial disease
Sumit Parikh et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2009)
PDH E1β deficiency with novel mutations in two patients with Leigh syndrome
E. Quintana et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2009)
Four novel PDHA1 mutations in pyruvate dehydrogenase deficiency
E. Ostergaard et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2009)
Efficacy of idebenone for respiratory failure in a patient with Leigh syndrome: A long-term follow-up study
Kazuhiro Haginoya et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2009)
Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy
Valeria Tiranti et al.
NATURE MEDICINE (2009)
Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-Deficient glioblastoma
Tim F. Cloughesy et al.
PLOS MEDICINE (2008)
Therapeutic potential of pyruvate therapy for mitochondrial diseases
Masashi Tanaka et al.
MITOCHONDRION (2007)
Mitochondrial complex I encephalomyopathy and cerebral 5-methyltetrahydrofolate deficiency
V. T. Ramaekers et al.
NEUROPEDIATRICS (2007)
Early-onset ophthalmoplegia in Leigh-like syndrome due to NDUFV1 mutations
Vincent Laugel et al.
PEDIATRIC NEUROLOGY (2007)
Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations
Luis Carlos Lopez et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy
Tina D. Jeppesen et al.
BRAIN (2006)
Dichloroacetate causes toxic neuropathy in MELAS - A randomized, controlled clinical trial
P Kaufmann et al.
NEUROLOGY (2006)
Leigh syndrome associated with mitochondrial complex I deficiency due to a novel mutation in the NDUFS1 gene
MA Martín et al.
ARCHIVES OF NEUROLOGY (2005)
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
JT Rodgers et al.
NATURE (2005)
Coenzyme Q- responsive Leigh's encephalopathy in two sisters
L Van Maldergem et al.
ANNALS OF NEUROLOGY (2002)
Dichloroacetate therapy in Leigh syndrome with a mitochondrial T8993C mutation
T Fujii et al.
PEDIATRIC NEUROLOGY (2002)
分享论文
